Global Laser Atherectomy Devices Market Size By Type (Computer Control, Others), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Laser Atherectomy Devices Market was valued at USD 1.2 billion in 2023 and is expected to reach USD 2.5 billion by 2031, expanding at a CAGR of 9.7% during the forecast period from 2023 to 2031. The increasing prevalence of peripheral arterial disease (PAD) and coronary artery disease (CAD), coupled with the demand for minimally invasive surgical techniques, is significantly propelling the market growth. Laser atherectomy devices provide precise plaque removal with reduced vascular trauma, enhancing procedural safety and patient outcomes. Rising geriatric population and favorable reimbursement policies are also bolstering the market's expansion.

Drivers:

1. Growing Burden of Cardiovascular Diseases:

With a global rise in conditions such as PAD and CAD, there is an increasing demand for advanced interventional procedures like laser atherectomy. These devices allow for precise ablation of plaque in complex and calcified lesions, making them critical tools in interventional cardiology.

2. Technological Advancements in Laser Devices:

Innovations such as excimer laser technology, reduced catheter profiles, and real-time imaging compatibility have enhanced the efficacy and safety of laser atherectomy systems. These advancements are making them more attractive compared to traditional methods.

3. Preference for Minimally Invasive Procedures:

Laser atherectomy is less invasive than surgical options, with lower complication rates, faster recovery times, and reduced hospital stays. These benefits are encouraging both clinicians and patients to opt for laser-based therapies.

Restraints:

1. High Procedure and Equipment Costs:

The initial investment in laser atherectomy systems and ongoing operational expenses pose significant financial challenges, particularly in low-income or resource-constrained healthcare systems.

2. Lack of Skilled Professionals:

Effective utilization of laser atherectomy devices requires specialized training. A shortage of trained interventional cardiologists and radiologists may hinder widespread adoption in some regions.

Opportunity:

1. Emerging Markets and Increasing Healthcare Access:

Growing healthcare infrastructure and increased awareness in Asia-Pacific, Latin America, and the Middle East are creating new opportunities for market players to expand into underpenetrated regions.

2. Integration with Imaging and AI Technologies:

The integration of laser atherectomy with advanced imaging tools and AI-powered navigation systems can enhance precision and procedural outcomes, offering untapped market potential.

Market by System Type Insights:

Based on system type, the Excimer Laser Atherectomy Devices segment held the largest market share in 2023. These systems are widely adopted due to their ability to vaporize atherosclerotic plaque with minimal thermal damage. Their effectiveness in treating in-stent restenosis and complex lesion types positions them as the preferred modality. The segment is expected to maintain dominance through 2031, driven by ongoing product enhancements and increasing clinical adoption.

Market by End-use Insights:

The Hospitals and Surgical Centers segment emerged as the dominant end-use category in 2023, accounting for over 60% of global revenue. These facilities are equipped with the infrastructure and skilled professionals required for laser atherectomy procedures. Meanwhile, the Ambulatory Surgical Centers (ASCs) segment is expected to grow at the highest CAGR, owing to their cost-effectiveness, shorter wait times, and patient preference for outpatient procedures.

Market by Regional Insights:

North America led the global laser atherectomy devices market in 2023, owing to high disease prevalence, advanced healthcare systems, and strong presence of key market players. Europe followed closely, supported by favorable reimbursement frameworks and rising awareness of PAD. However, Asia-Pacific is projected to be the fastest-growing region through 2031, driven by improving healthcare infrastructure, rising cardiovascular disease burden, and government initiatives promoting early diagnosis and treatment.

Competitive Scenario:

Key players in the global laser atherectomy devices market include Philips (Spectranetics), Boston Scientific Corporation, Cardiovascular Systems Inc., Ra Medical Systems, Medtronic plc, Abbott Laboratories, AngioDynamics, Inc., Avinger Inc., and BD (Becton, Dickinson and Company). These companies are focused on developing next-generation devices, entering strategic collaborations, and expanding geographically.

Key Market Developments:

2023: Philips introduced a new-generation excimer laser system with real-time lesion visualization features for enhanced procedural precision.

2024: Boston Scientific announced a partnership with a major university hospital to conduct a clinical trial on laser atherectomy efficacy in below-the-knee PAD cases.

2025: Ra Medical Systems secured FDA clearance for an advanced laser catheter with integrated AI guidance, aimed at improving success rates in complex occlusions.

Scope of Work – Global Laser Atherectomy Devices Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.5 billion

CAGR (2023–2031) 9.7%

Key Segments by System Type Excimer Laser Atherectomy, Others

Key Segments by End-use Hospitals & Surgical Centers, ASCs

Leading Region North America

Key Players Philips, Boston Scientific, Medtronic, etc.

Growth Drivers Rising cardiovascular diseases, tech innovation

Opportunities AI integration, Emerging market